Anakinra for COVID-19 Respiratory Symptoms

NCT04364009 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

71

Enrollment

OTHER

Sponsor class

Stopped Efficiency and safety reasons

Conditions

COVID-19 Infection
ANAKINRA Treatment
Optimized Standard of Care (oSOC)

Interventions

DRUG: Anakinra plus oSOC
DRUG: oSOC

Sponsor

University Hospital, Tours

Collaborators

[object Object]
[object Object]